James M Daly Net Worth & Insider Trades
James M Daly - Director, Halozyme Therapeutics, Inc
What is James M Daly's Net Worth?
The current estimated net worth of Halozyme Therapeutics, Inc's Director, James M Daly, is estimated to be about $32.28M . James M Daly owns about 21,002 units of Halozyme Therapeutics, Inc common stock. In the last 6 years at Halozyme Therapeutics, Inc, James M Daly has sold an estimated value of $1.42M worth.
What is James M Daly's Past Insider Trading?
James M Daly's largest sale order was 34,337 units , worth over $1M on August 13, 2020. In total, James M Daly has made about 9 transactions over 6 years of their time at Halozyme Therapeutics, Inc. James M Daly usually trades in May, with the busiest year in 2020. The most recent transaction was a sale order of 10,363 units , worth over $418.8K on November 25, 2020.
James M Daly
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is James M Daly's' Mailing Address?
- Mailing address is Incyte Corporation Experimental Station Rte 141 & Henry Clay Rd. Bldg E336 Wilmington DE 19880 DE
Halozyme Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Helen I. Torley | 2020 | $791,440 | - | $2,500,018 | $2,500,001 | $712,270 | $15,147 | $6,518,876 |
| Helen I. Torley | 2019 | $761,000 | - | $2,184,130 | $2,184,128 | $712,296 | $15,572 | $5,857,126 |
| Helen I. Torley | 2018 | $725,000 | - | $2,115,640 | $2,115,631 | $831,665 | $11,733 | $5,799,669 |
| Elaine D. Sun | 2020 | $395,833 | $150,000 | $1,500,269 | $1,000,008 | $180,352 | $133,399 | $3,359,861 |
| Laurie D. Stelzer | 2020 | $93,225 | - | - | - | - | $77,996 | $171,221 |
| Laurie D. Stelzer | 2019 | $495,000 | $2,500 | $750,016 | $750,005 | $231,660 | $16,939 | $2,246,120 |
| Laurie D. Stelzer | 2018 | $470,000 | - | $575,018 | $575,009 | $323,489 | $9,409 | $1,952,925 |
| Masaru Matsuda | 2020 | $440,000 | $50,000 | $500,019 | $500,008 | $203,940 | $13,901 | $1,707,868 |
| Michael J. LaBarre | 2020 | $475,000 | - | $650,009 | $650,007 | $220,163 | $15,018 | $2,010,197 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1159036/000115903621000019/halodefproxy2021.htm
What are Halozyme Therapeutics, Inc's Past Insider Trades?
Halozyme Therapeutics, Inc's most recent insider trade came on March 9, 2023 by Helen Torley who sold 30,000 units worth $1.31M . In the last 16 years, insiders at Halozyme Therapeutics, Inc have sold an estimated value of $148.21M and bought an estimated value of $83.48M worth of shares. Insider trading is most common in February, with the busiest year in 2007. The most active traders at the company are Helen Torley, PRESIDENT AND CEO, Gregory Ian Frost, CEO, and Randal J Kirk .
HALOZYME THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||